Literature DB >> 29227048

The prevalence of Eustachian tube dysfunction symptoms in patients with chronic rhinosinusitis.

Navarat Tangbumrungtham1,2, Vishal S Patel1, Andrew Thamboo1,3, Zara M Patel1, Jayakar V Nayak1, Yifei Ma1, Garret Choby1,4, Peter H Hwang1.   

Abstract

BACKGROUND: While Eustachian tube dysfunction (ETD) is a known comorbidity of chronic rhinosinusitis (CRS), the prevalence of ETD symptoms in the CRS population is poorly understood. We sought to determine the cross-sectional prevalence of ETD in patients with CRS using the validated Eustachian Tube Dysfunction Questionnaire (ETDQ-7) and to correlate ETDQ-7 scores with 22-item Sino-Nasal Outcome Test (SNOT-22) scores, endoscopy scores, and computed tomography (CT) scores.
METHODS: A total of 101 patients with confirmed CRS completed the ETDQ-7 and SNOT-22 at their initial visit to our rhinology clinic. Lund-Mackay CT and Lund-Kennedy endoscopy scores were also obtained. Spearman's correlation coefficient (ρ) was calculated.
RESULTS: Among the 101 patients, 49 patients (48.5%) had an ETDQ-7 score of ≥14.5, signifying clinically significant ETD. The mean ± standard deviation (SD) ETDQ-7 score of the entire cohort was 17.8 ± 10.1. There was a moderately strong correlation between ETDQ-7 and the SNOT-22 ear subdomain (ρ = 0.691, p < 0.001). The correlation coefficient between ETDQ-7 and total SNOT-22 scores was ρ = 0.491 (p < 0.001), indicating moderate correlation. ETDQ-7 scores were poorly correlated to objective measures of sinonasal disease, including Lund-Mackay CT score (ρ = -0.055, p = 0.594) and Lund-Kennedy endoscopy score (ρ = -0.099, p = 0.334).
CONCLUSION: Symptoms of ETD are highly prevalent among patients with CRS as documented by patient-reported outcome measures. The correlation between ETDQ-7 scores and SNOT-22 ear subdomain scores is moderately strong, while the correlation between ETDQ-7 scores and SNOT-22 scores is moderate. ETD severity does not correlate with CT score or nasal endoscopy score.
© 2017 ARS-AAOA, LLC.

Entities:  

Keywords:  Eustachian tube dysfunction; chronic rhinosinusitis; ear disease; ear fullness; ear pressure; otologic symptoms; sinusitis

Mesh:

Year:  2017        PMID: 29227048     DOI: 10.1002/alr.22056

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN: 2042-6976            Impact factor:   3.858


  7 in total

1.  Hearing loss and middle ear symptoms in aspirin-exacerbated respiratory disease.

Authors:  Jyotsna Mullur; Joseph Singer; Rachel Roditi; Katherine N Cahill
Journal:  J Allergy Clin Immunol Pract       Date:  2018-12-08

2.  Changes in symptoms of Eustachian tube dysfunction after nasal surgery.

Authors:  Il Hwan Lee; Do Hyun Kim; Sung Won Kim; Soo Whan Kim
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-03-29       Impact factor: 3.236

3.  Eustachian tube dysfunction in patients with house dust mite-allergic rhinitis.

Authors:  Yun Ma; Maojin Liang; Peng Tian; Xiang Liu; Hua Dang; Qiujian Chen; Hua Zou; Yiqing Zheng
Journal:  Clin Transl Allergy       Date:  2020-07-15       Impact factor: 5.871

4.  The Impact of Medical Comorbidities on Patient Satisfaction in Chronic Rhinosinusitis.

Authors:  Amarbir S Gill; Joshua Hwang; Angela M Beliveau; Jeremiah A Alt; Edward Bradley Strong; Machelle D Wilson; Toby O Steele
Journal:  Ann Otol Rhinol Laryngol       Date:  2021-05-12       Impact factor: 1.547

5.  Endoscopic sinus surgery and aspirin desensitization improve otologic-specific SNOT-22 scores.

Authors:  James G Naples; Andrew Corr; Siddhant Tripathi; Morgan Berman; Jason A Brant; Michael J Ruckenstein; John Bosso
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2020-10-17

6.  Clinical Relevance and Advantages of Intradermal Test Results in 371 Patients with Allergic Rhinitis, Asthma and/or Otitis Media with Effusion.

Authors:  David S Hurst; Alan B McDaniel
Journal:  Cells       Date:  2021-11-18       Impact factor: 6.600

7.  Prevalence of and Factors Associated With Eustachian Tube Dysfunction Among the Public in Taif, Saudi Arabia.

Authors:  Wahaj A Altalhi; Abeer I Alsulaimani; Zouhor A Alhossaini; Rawan M Alharthi; Zohour A Almalki; Wjood A Altalhi; Shrooq H Alswat; Ghaliah O Alnefaie
Journal:  Cureus       Date:  2022-07-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.